Salud financiera de hoja de balance de CareMax

Salud financiera controles de criterios 1/6

CareMax tiene un patrimonio de los accionistas total de $61.4M y una deuda total de $366.2M, lo que sitúa su ratio deuda-patrimonio en 596%. Sus activos y pasivos totales son $623.3M y $561.9M respectivamente.

Información clave

1,828.7%

Ratio deuda-patrimonio

US$373.11m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	US$41.48m
Patrimonio	US$20.40m
Total pasivo	US$593.80m
Activos totales	US$614.20m

Actualizaciones recientes sobre salud financiera

Recent updates

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Jun 20

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

May 13

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Mar 11

CareMax: Numbers Are Strong, Compelling Value On Offer

Sep 16

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

Aug 09

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

Jul 02

CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries

Oct 18

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($183.3M) de CMAX no cubren sus pasivos a corto plazo ($438.8M).

Pasivo a largo plazo: Los activos a corto plazo de CMAX ($183.3M) superan a sus pasivos a largo plazo ($123.0M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de CMAX (489.4%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de CMAX ha crecido de 67.3% a 596% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: CMAX tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: CMAX tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 55% cada año

Salud financiera de hoja de balance de CareMax

Salud financiera controles de criterios 1/6

Información clave

Actualizaciones recientes sobre salud financiera

CareMax, Inc. announced delayed annual 10-K filing

CareMax Announces 1-for-30 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

CareMax Receives Non-Compliance Notice From Nasdaq

CareMax, Inc. announced delayed 10-Q filing

Recent updates

CareMax, Inc. announced delayed annual 10-K filing

Price target decreased by 42% to US$26.00

Price target decreased by 17% to US$37.33

CareMax Announces 1-for-30 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

CareMax Receives Non-Compliance Notice From Nasdaq

New major risk - Share price stability

New minor risk - Market cap size

Consensus EPS estimates fall by 64%

Price target increased by 9.1% to US$6.00

Consensus EPS estimates fall by 105%

New minor risk - Profitability

Caremax, Inc. Reports Unaudited Goodwill Impairment for the Three Months Ended September 30, 2023

CareMax, Inc. to Report Q3, 2023 Results on Nov 09, 2023

CareMax, Inc. Announces Resignation of David J. Shulkin as A Member of the Board of Director

Consensus EPS estimates fall by 18%, revenue upgraded

Price target decreased by 11% to US$6.00

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Caremax, Inc. Raises Revenue Guidance for the Full Year of 2023

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Consensus EPS estimates upgraded to US$0.28 loss, revenue downgraded

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

Caremax, Inc. Reaffirms Full Year 2023 Guidance

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates upgraded to US$0.42 loss

Consensus EPS estimates upgraded to US$0.49 loss, revenue downgraded

Consensus revenue estimates fall by 12%

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$8.50

CareMax, Inc. Appoints Ralph De La Torre as Director

Consensus forecasts updated

High number of new and inexperienced directors

CareMax, Inc. (NasdaqGS:CMAX) completed the acquisition of Steward National Care Network, Inc., Steward Integrated Care Network, Inc. and Steward Accountable Care Network, Inc. from Steward Health Care System LLC.

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Caremax, Inc. Raises Earnings Guidance for the Full Year 2022

CareMax, Inc. Approves Appointment of Ryan O'quinn as Board of Director

CareMax, Inc. to Report Q3, 2022 Results on Nov 09, 2022

CareMax, Inc., Annual General Meeting, Nov 02, 2022

CareMax: Numbers Are Strong, Compelling Value On Offer

Price target decreased to US$11.10

Consensus estimates of losses per share improve by 14%

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CareMax, Inc. Revises Earnings Guidance for the Full Year 2022

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

CareMax, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Price target decreased to US$11.00

High number of new and inexperienced directors

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

CareMax, Inc. (NasdaqGS:CMAX) entered into an agreement to acquire Steward National Care Network, Inc., Steward Integrated Care Network, Inc. and Steward Accountable Care Network, Inc. from Steward Health Care System LLC for approximately $135 million.

Consensus forecasts updated

Price target decreased to US$12.00

Caremax, Inc. Provides Earnings Outlook for the Full Year 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

CareMax, Inc. to Report Q1, 2022 Results on May 10, 2022

High number of new and inexperienced directors

Consensus estimates of losses per share improve by 40%

Price target decreased to US$13.25

Consensus forecasts updated

Caremax, Inc. Provides Revenue Guidance for the Full Year 2022

Full year 2021 earnings: EPS misses analyst expectations

CareMax, Inc. to Report Q4, 2021 Results on Mar 08, 2022

CareMax, Inc. Announces Board Changes

Third quarter 2021 earnings released: US$0.035 loss per share (vs US$0.029 loss in 3Q 2020)

High number of new and inexperienced directors

CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries

CareMax, Inc. announced delayed 10-Q filing

First quarter 2021 earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance